GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » FCF Yield %

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) FCF Yield % : -1.05 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Intelligent Medicine Acquisition's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $279.41 Mil. Therefore, Intelligent Medicine Acquisition's FCF Yield % for today is -1.05%.

The historical rank and industry rank for Intelligent Medicine Acquisition's FCF Yield % or its related term are showing as below:

IQMDU' s FCF Yield % Range Over the Past 10 Years
Min: -1.05   Med: 0   Max: 0
Current: -1.05

IQMDU's FCF Yield % is not ranked
in the Diversified Financial Services industry.
Industry Median: -1.545 vs IQMDU: -1.05

Intelligent Medicine Acquisition's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

Intelligent Medicine Acquisition FCF Yield % Historical Data

The historical data trend for Intelligent Medicine Acquisition's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition FCF Yield % Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
FCF Yield %
- -

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
FCF Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Intelligent Medicine Acquisition's FCF Yield %

For the Shell Companies subindustry, Intelligent Medicine Acquisition's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelligent Medicine Acquisition's FCF Yield % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's FCF Yield % falls into.


Intelligent Medicine Acquisition FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Intelligent Medicine Acquisition's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.867 /
=N/A%

Intelligent Medicine Acquisition's annualized FCF Yield % for the quarter that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.452 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Medicine Acquisition FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Intelligent Medicine Acquisition FCF Yield % Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » FCF Yield %
Comparable Companies
IFIN WAVC FRW SHCA AVAC OCA ISLE BIOT DWIN TRCA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Website
https://iqmdspac.com
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817

Intelligent Medicine Acquisition (Intelligent Medicine Acquisition) Headlines

From GuruFocus

Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

By Business Wire Business Wire • 02-03-2023

Intelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021

By Business Wire Business Wire • 12-23-2021

Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares

By Business Wire Business Wire • 04-26-2023

Intelligent Medicine Acquisition Corp. Announces Closing of Upsized $207,000,000 Initial Public Offering

By Business Wire Business Wire • 11-10-2021